Results 71 to 80 of about 1,288 (185)
Open Forum Infectious Diseases, 2022 Background There are limited oral treatment options for patients with fungal infections who fail currently available antifungals or have an infection caused by resistant organisms.
G. Thompson +4 more
semanticscholar +1 more source
Nine Things Genomics Can Tell Us About Candida auris [PDF]
, 2020 FUNDING RF was supported by MRC grant MR/N006364/2 and a Wellcome Trust Seed Award (215239/Z/19/Z). ACKNOWLEDGMENTS We would like to give thanks to Carolina Coelho for helpful discussions and assistance with Figure 1 and Jose Muñoz for valuable feedback ...
Childers, Delma S +2 more
core +1 more source
Rezafungin—mechanisms of action, susceptibility and resistance: Similarities and differences with the other echinocandins [PDF]
, 2020 Rezafungin (formerly CD101) is a new β-glucan synthase inhibitor that is chemically related with anidulafungin. It is considered the first molecule of the new generation of long-acting echinocandins. It has several advantages over the already approved by
Garcia, Guillermo Manuel
core +1 more source
Antimicrobial Agents and Chemotherapy, 2021 Candida auris is an emerging pathogen that has rapidly spread to many countries on multiple continents. Invasive infections caused by this species are associated with significant mortality, and treatment options are limited due to antifungal resistance ...
N. Wiederhold +6 more
semanticscholar +1 more source
Chemistry &Biodiversity, Volume 23, Issue 2, February 2026.This study describes the isolation and characterization of potent bioactive compounds from the fungal strain Neonothopanus nambi, followed by structural elucidation. The compounds shown are dimeric aristolane‐type sesquiterpenoids, identified as aurisins D (1) and B (2).
Syeda J. Khalid +8 more
wiley +1 more source
Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus
Women's Health Reports, 2022 Background: Recurrent vulvovaginal candidiasis (RVVC), defined as three or more confirmed infections over 1 year, occurs in up to 10% of women. In these women, the objective is often symptomatic control rather than mycologic cure.
Nancy A. Phillips +4 more
doaj +1 more source
Epidemiology and Outcomes of Sporotrichosis: A Descriptive Real‐World Analysis From a Global Cohort
Mycoses, Volume 69, Issue 2, February 2026.ABSTRACT Background Sporotrichosis is a dimorphic fungal infection of increasing global relevance. Although usually cutaneous or lymphocutaneous, disseminated disease occurs in immunocompromised hosts. Large‐scale data on its epidemiology, treatment and outcomes remain limited. Objectives To characterise the clinical features, comorbidities, antifungal
Samantha Schapiro +8 more
wiley +1 more source
Hope in the Treatment of Candida Vaginitis: Ibrexafungerp
Türk Mikrobiyoloji Cemiyeti Dergisi, 2021 Candida vaginitis (CV) is a neglected but growing public health problem. It is estimated that three out of four women have had at least one CV attack. The diagnosis and treatment of CV is often inadequate due to the tendency of women to self-diagnose and use over-the-counter drugs when they have vaginal or vulvar complaints, and clinicians plan ...
openaire +1 more source
Candida auris in Austria—What Is New and What Is Different
Journal of Fungi, 2023 Candida auris is a novel and emerging pathogenic yeast which represents a serious global health threat. Since its first description in Japan 2009, it has been associated with large hospital outbreaks all over the world and is often resistant to more than
Kathrin Spettel +10 more
doaj +1 more source
Terapêutica antifúngica: novas moléculas, novas formas de administração e diferentes estratégias para alcançar a toxicidade seletiva [PDF]
, 2021 Nos últimos anos verificou-se um aumento das infeções fúngicas invasivas, devido ao aumento da esperança de vida e do número de doentes imunodeprimidos e ao aparecimento de resistência aos antifúngicos.
Moreira, Marta Alexandra Macedo
core